newsfilter
← Latest News
PR Newswire·

Orexo's flagship pharmaceutical pipeline asset OX124 enters pivotal trial

UPPSALA, Sweden, July 16, 2021 /PRNewswire/ -- Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY) today announces that the company has successfully initiated the pivotal trial (OX124-002) for its lead pharmaceutical pipeline asset, OX124. The first cohort of hea